Andres Fernandez-Laguna

Stockholm, AB, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Pharmacotherapy of cardiovascular diseases from herbs and pills to nucleic acids.

Pharmacotherapy of cardiovascular diseases from herbs and pills to nucleic acids.

Journal: European heart journal

Published: November 27, 2024

Impact of elevated lipoprotein(a) on coronary artery disease phenotype and severity.

Impact of elevated lipoprotein(a) on coronary artery disease phenotype and severity.

Journal: European journal of preventive cardiology

Published: June 22, 2023

Omega-3 Polyunsaturated Fatty Acids Decrease Aortic Valve Disease Through the Resolvin E1 and ChemR23 Axis.

Omega-3 Polyunsaturated Fatty Acids Decrease Aortic Valve Disease Through the Resolvin E1 and ChemR23 Axis.

Journal: Circulation

Published: June 09, 2020

Proteoglycan 4 is Increased in Human Calcified Aortic Valves and Enhances Valvular Interstitial Cell Calcification.

Proteoglycan 4 is Increased in Human Calcified Aortic Valves and Enhances Valvular Interstitial Cell Calcification.

Journal: Cells

Published: January 22, 2020

Chemerin inhibits vascular calcification through ChemR23 and is associated with lower coronary calcium in chronic kidney disease.

Chemerin inhibits vascular calcification through ChemR23 and is associated with lower coronary calcium in chronic kidney disease.

Journal: Journal of internal medicine

Published: June 15, 2019

Opposing Effects on Vascular Smooth Muscle Cell Proliferation and Macrophage-induced Inflammation Reveal a Protective Role for the Proresolving Lipid Mediator Receptor ChemR23 in Intimal Hyperplasia.

Opposing Effects on Vascular Smooth Muscle Cell Proliferation and Macrophage-induced Inflammation Reveal a Protective Role for the Proresolving Lipid Mediator Receptor ChemR23 in Intimal Hyperplasia.

Journal: Frontiers in pharmacology

Published: September 30, 2018

The G-protein coupled receptor ChemR23 determines smooth muscle cell phenotypic switching to enhance high phosphate-induced vascular calcification.

The G-protein coupled receptor ChemR23 determines smooth muscle cell phenotypic switching to enhance high phosphate-induced vascular calcification.

Journal: Cardiovascular research

Published: September 20, 2018

ERV1/ChemR23 Signaling Protects Against Atherosclerosis by Modifying Oxidized Low-Density Lipoprotein Uptake and Phagocytosis in Macrophages.

ERV1/ChemR23 Signaling Protects Against Atherosclerosis by Modifying Oxidized Low-Density Lipoprotein Uptake and Phagocytosis in Macrophages.

Journal: Circulation

Published: May 10, 2018

Association of a variant in the gene encoding for ERV1/ChemR23 with reduced inflammation in visceral adipose tissue from morbidly obese individuals.

Association of a variant in the gene encoding for ERV1/ChemR23 with reduced inflammation in visceral adipose tissue from morbidly obese individuals.

Journal: Scientific reports

Published: July 28, 2017

Aspirin-triggered lipoxin A4 inhibits atherosclerosis progression in apolipoprotein E-/- mice.

Aspirin-triggered lipoxin A4 inhibits atherosclerosis progression in apolipoprotein E-/- mice.

Journal: British journal of pharmacology

Published: June 17, 2016

Iron alters valvular interstitial cell function and is associated with calcification in aortic stenosis.

Iron alters valvular interstitial cell function and is associated with calcification in aortic stenosis.

Journal: European heart journal

Published: November 16, 2015

Aspirin-triggered 15-epi-lipoxin A₄ signals through FPR2/ALX in vascular smooth muscle cells and protects against intimal hyperplasia after carotid ligation.

Aspirin-triggered 15-epi-lipoxin A₄ signals through FPR2/ALX in vascular smooth muscle cells and protects against intimal hyperplasia after carotid ligation.

Journal: International journal of cardiology

Published: October 30, 2014

Showing 1-12 of 14

Last Updated: 09/26/2026